Dana Pe'er

41PUBLICATIONS
346CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Apr 17, 2026
Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing.

|Mar 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Mar 26, 2026
Distinctive DNA sequence features define epigenetic longevity of inflammatory memory.

Christopher J Cowley, Sairaj M Sajjath, Luis F Soto-Ugaldi

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Dec 11, 2025
Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer.

Alejandro Jiménez-Sánchez, Sitara Persad, Akimasa Hayashi

|Sep 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.

Wungki Park, Catherine O'Connor, Joanne Chou

Pageof 7

Frequent Collaborators

15 joint publications

Travis J Hollmann

10 joint publications

Tal Nawy

9 joint publications

Christine Iacobuzio-Donahue

8 joint publications

Linas Mazutis